Internal Medicine, Infectious Disease · Kokomo, IN
NPI
1356550057
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1907 W Sycamore St Fl 3
Kokomo, IN, 46901
Phone (765) 236-8363
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
593 services
Medicare patients, 2024
203
Average age 73
Drug cost, 2024
$959K
666 prescriptions
Company payments, 2025
$638
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michele B Weiberg was code 99232 (hospital e&m - subsequent), 225 times for 89 patients. In total Michele B Weiberg billed 593 services in 16 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 225 | 89 | $57.04 | $13K |
| 99222 Hospital E&M - Initial | Facility | 120 | 112 | $92.08 | $11K |
| 99214 Office E&M - Established | Office | 119 | 76 | $84.75 | $10K |
| 99231 Hospital E&M - Subsequent | Facility | 38 | 29 | $36.32 | $1,380 |
| 99204 Office E&M - New | Office | 33 | 33 | $114.12 | $3,766 |
| 99213 Office E&M - Established | Office | 24 | 23 | $65.14 | $1,563 |
By year: 2022 $45K for 701 services; 2023 $50K for 623 services; 2024 $45K for 593 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michele B Weiberg prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 112 prescriptions and refills. In total Michele B Weiberg wrote 666 Medicare prescriptions that cost $959K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 112 | 112 | Under 11 | $472K |
| Doxycycline Hyclate Generic | 51 | 67 | 11 | $1,065 |
| Azithromycin Generic | 38 | 44 | Under 11 | $424 |
| Amoxicillin Generic | 36 | 42 | Under 11 | $167 |
| Dovato Dolutegravir Sodium/Lamivudine | 35 | 35 | Under 11 | $102K |
| Vancomycin Hcl Generic | 35 | 35 | Under 11 | $1,816 |
| Cephalexin Generic | 30 | 50 | Under 11 | $13K |
| Acyclovir Generic | 27 | 29 | Under 11 | $295 |
| Cresemba Isavuconazonium Sulfate | 17 | 17 | Under 11 | $98K |
| Meropenem Generic | 17 | 17 | Under 11 | $5,526 |
| Itraconazole Generic | 16 | 32 | Under 11 | $8,348 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 15 | 15 | Under 11 | $4,158 |
| Cefuroxime Cefuroxime Axetil | 14 | 17 | Under 11 | $926 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 14 | 14 | Under 11 | $120 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 13 | 13 | Under 11 | $67K |
Brand drugs: 234 claims; generic drugs: 432 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michele B Weiberg $638 ($638 in general payments such as food, travel and fees) from 16 companies. The largest payer was ViiV Healthcare Company with $97.76.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 4 | $97.76 |
| Baxter Healthcare BAX | 3 | $70.33 |
| Gilead Sciences, Inc. GILD | 3 | $65.71 |
| Merck Sharp & Dohme LLC MRK | 3 | $64.65 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $50.1 |
| Cumberland Pharmaceuticals, Inc. CPIX | 2 | $46.92 |
| Aimmune Therapeutics, Inc. | 2 | $40.73 |
| Grifols USA, LLC | 2 | $39.03 |
| Pfizer Inc. PFE | 1 | $27.39 |
| Pulmonx Corporation LUNG | 1 | $21.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.